Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock

Lancet

Volumn 363, Issue 9404, 2004, Pages 203-209

  Pathan, Nazima ^a,e   Hemingway, Cheryl A ^a   Alizadeh, Ash A ^c   Stephens, Alick C ^a   Boldrick, Jennifer C ^c   Oragui, Emmanuelle E ^a   McCabe, Colm ^b   Welch, Steven B ^a   Whitney, Adeline ^c   O'Gara, Peter ^b   Nadel, Simon ^a   Relman, David A ^c,d   Harding, Sian E ^b   Levin, Michael ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^e IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEART MUSCLE DEPRESSANT FACTOR; INTERLEUKIN 6; PROTEIN P25;

ARTICLE; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; GENE CONTROL; GENE EXPRESSION; GENETIC CODE; GENETIC IDENTIFICATION; HUMAN; IN VITRO STUDY; INFLAMMATORY CELL; MENINGOCOCCOSIS; MYOCARDIAL DISEASE; ONSET AGE; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN STABILITY; SEPTIC SHOCK;

EID: 9144265427     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)15326-3     Document Type: Article

References (28)

1. Thalinger A.R., Lefer A.M. Cardiac actions of a myocardial depressant factor isolated from shock plasma. Proc Soc Exp Biol Med. 136:1971;354-358.
2. Parrillo J.E., Burch C., Shelhamer J.H., Parker M.M., Natanson C., Schuette W. A. circulating myocardial depressant substance in humans with septic shock: septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest. 76:1985;1539-1553.
3. Kumar A., Thota V., Dee L., Olson J., Uretz E., Parrillo J.E. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med. 183:1996;949-958.
4. Sagher U., Rosen H., Sarel O., Becker Y. Studies on a pancreatic cardiodepressant factor. Circ Shock. 19:1986;319-326.
5. Bennasayag C., Christeff N., Auclair M.C., et al. Early released lipid soluble cardiodepressant factor and elevated oestrogenic substances in human septic shock. Eur J Clin Invest. 14:1984;288-294.
6. Balligand J.L., Ungureanu D., Kelly R.A., et al. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest. 91:1993;2314-2319.
7. Mercier J.C., Beaufils F., Hartmann J.F., Azema D. Hemodynamic patterns of meningococcal shock in children. Crit Care Med. 16:1988;27-33.
8. Pathan N., Sandiford C., Harding S.E., Levin M. Characterization of a myocardial depressant factor in meningococcal septicemia. Crit Care Med. 30:2002;2191-2198.
9. Pollack M.M., Patel K.M., Ruttimann U.E. PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med. 24:1996;743-752.
10. Wang E., Miller L.D., Ohnmacht G.A., Liu E.T., Marincola F.M. High-fidelity mRNA amplification for gene profiling. Nat Biotechnol. 18:2000;457-459.
11. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:2000;503-511.
12. Liu CL. Data processing of time course data. http://genetics.stanford. edu/~cliu/proc.html (accessed Nov 3, 2003).
13. Eisen M. Microarrays.org: software. http://www.microarrays.org/software. html (accessed Oct 1, 2003).
14. Brazma A., Hingamp P., Quackenbush J., et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 29:2001;365-371.
15. Stanford Microarray Database. http://genome-www5.stanford.edu/MicroArray/ SMD/ (accessed Oct 1, 2003).
16. Levin M., Quint P.A., Goldstein B., et al. Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. Lancet. 356:2000;961-967.
17. Gardlund B., Sjolin J., Nilsson A., Roll M., Wickerts C.J., Wretlind B. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis. 172:1995;296-301.
18. Hazelzet J.A., van der Voort E., Lindemans J., ter Heerdt P.G., Neijens H.J. Relation between cytokines and routine laboratory data in children with septic shock and purpura. Intensive Care Med. 20:1994;371-374.
19. Hazelzet J.A., Risseeuw-Appel I.M., Kornelisse R.F., et al. Age-related differences in outcome and severity of DIC in children with septic shock and purpura. Thromb Haemost. 76:1996;932-938.
20. van Deuren M., van der Ven-Jongekrijg J., Bartelink A.K., van Dalen R., Sauerwein R.W., van der Meer J.W. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis. 172:1995;433-439.
21. Klein N.J., Ison C.A., Peakman M., et al. The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis. J Infect Dis. 173:1996;172-179.
22. Chan B., Kalabalikis P., Klein N., Heyderman R., Levin M. Assessment of the effect of candidate anti-inflammatory treatments on the interaction between meningococci and inflammatory cells in vitro in a whole blood model. Biotherapy. 9:1996;221-228.
23. Heyderman R.S., Ison C.A., Peakman M., Levin M., Klein N.J. Neutrophil response to Neisseria meningitidis: inhibition of adhesion molecule expression and phagocytosis by recombinant bactericidal/permeability-increasing protein (rBPI21). J Infect Dis. 179:1999;1288-1292.
24. Finkel M.S., Oddis C.V., Jacob T.D., Watkins S.C., Hattler B.G., Simmons R.L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 257:1992;387-389.
25. Kinugawa K., Takahashi T., Kohmoto O., et al. Nitric oxide-mediated effects of interleukin-6 on [Ca2+]i and cell contraction in cultured chick ventricular myocytes. Circ Res. 75:1994;285-295.
26. Sugishita K., Kinugawa K., Shimizu T., et al. Cellular basis for the acute inhibitory effects of IL-6 and TNF-alpha on excitation-contraction coupling. J Mol Cell Cardiol. 31:1999;1457-1467.
27. Hovels-Gurich H.H., Vazquez-Jimenez J.F., Silvestri A., et al. Production of proinflammatory cytokines and myocardial dysfunction after arterial switch operation in neonates with transposition of the great arteries. J Thorac Cardiovasc Surg. 124:2002;811-820.
28. Geppert A., Steiner A., Zorn G., et al. Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6. Crit Care Med. 30:2002;1987-1994.